Smoking and Periodontitis

More than 4,000 toxins are present in cigarette smoke, contributing to various health issues, particularly in oral health:

Carbon monoxide: A colorless, odorless gas that interferes with oxygen transport in the blood.
Oxidizing radicals: Reactive molecules that can damage cellular structures and lead to inflammation.
Carcinogens: Substances such as nitrosamines that have been proven to increase cancer risk.
Addictive psychoactive substances: Nicotine, which contributes to addiction and alters behavior and mood.

Smoking is associated with several oral health problems, including:

Halitosis (bad breath): Persistent foul odor that is often difficult to eliminate.
Dry mouth (xerostomia): Reduced saliva production that can lead to difficulty in speaking and swallowing.
Dental staining: Discoloration of teeth due to tar and nicotine, which can significantly affect aesthetics.
Periodontal disease (gum disease): An inflammatory condition affecting the supporting structures of teeth, leading to potential tooth loss.
Cancer: Increased risk of oral cancers, including cancers of the mouth, throat, and esophagus.

The literature indicates a strong correlation between cigarette smoking and the progression of periodontal disease:

Smokers are two to three times more likely to develop periodontal disease compared to non-smokers, demonstrating the substantial impact of tobacco on oral health.
Smokers are likely to lose more teeth than non-smokers due to the destructive effects of smoking on the periodontal tissues.
Higher incidence of attachment loss and periodontal destruction is observed in smokers than in former or never smokers, emphasizing the long-term effects of smoking.
The severity of periodontal disease is dose-dependent; heavy smokers (those who smoke more than 10 cigarettes per day) experience a greater risk of severe attachment loss, highlighting the need for smoking cessation programs.

Nonsmokers can also be affected by secondhand smoke (passive smoking), which poses significant health risks:

Research from NHANES III indicates that exposure to passive smoke doubles the likelihood of developing periodontitis, showcasing the importance of smoke-free environments.

Grading is crucial in assessing the progression rate of periodontitis, therapy responsiveness, and systemic health impact:

Grade A: Slow rate of progression, with direct evidence showing no loss over 5 years; often seen in non-smokers.
Grade B: Moderate rate of progression; indirect evidence shows bone loss of 0.25 to 1.0 mm over 5 years.
Grade C: Rapid rate of progression; includes cases of bone loss greater than 2mm over 5 years.
The 2017 World Workshop emphasizes the need to consider new evidence to shift grade assumptions in patients, enhancing personalized treatment plans.

Smoking is recognized as a critical factor that accelerates periodontal disease progression:

It alters treatment responsiveness and adversely influences systemic health, showcasing the integral role that smoking cessation plays in overall treatment success.
Smoking can lead to disease progression through defined stages, necessitating comprehensive management strategies for smokers.

Smoking affects multiple factors related to periodontal disease:

Oral microbial biofilms: Smokers exhibit increased colonization by harmful pathogens, such as Porphyromonas gingivalis, which plays a key role in periodontal disease.
Immune system: Smoking adversely affects immune response, resulting in decreased signs of inflammation, impaired gingival blood circulation, and reduced neutrophil function along with antibody production.
Bone metabolism: Smoking is linked to greater alveolar bone destruction than non-smokers, primarily due to nicotine’s suppression of osteoblasts and increased secretion of inflammatory cytokines, such as IL-6.

Several key cytokines play crucial roles in the inflammatory process related to smoking and periodontal disease:

Cytokine IL-1: Stimulates osteoclast activity, resulting in bone resorption and collagen breakdown, thus contributing to periodontal tissue loss.
Cytokine IL-6: Promotes bone resorption while inhibiting bone formation, creating an imbalance in alveolar bone metabolism.
Cytokine IL-8: Contributes to connective tissue destruction and further bone resorption, exacerbating periodontal disease.
Cytokine TNF-α: Induces collagen matrix breakdown and stimulates bone resorption, highlighting the destructive nature of the inflammatory response.
Prostaglandin E2 (PGE2): Stimulates matrix metalloproteinase (MMP) secretion, leading to enhanced bone resorption and further periodontal damage.

Chemicals and toxins present in cigarette smoke may negatively impact periodontal therapies:

They can delay wound healing and adversely affect fibroblasts and collagen production, which are critical for tissue repair.
Clinical studies indicate that smokers experience less reduction in probing depths and less clinical attachment gain following periodontal treatments, underscoring the challenge of treating smokers effectively.

Electronic Cigarettes:

These devices do not contain tobacco but heat liquid nicotine to produce vapor; however, the vapor is known to contain various toxins, and their long-term effects are still under investigation.

Waterpipe Smoking:

Commonly known as Hookah or Shisha, this method of smoking is associated with respiratory and cardiovascular problems and shows a higher intake of nicotine and carcinogens compared to traditional cigarettes, leading to increased periodontal issues, such as deeper pockets and attachment loss.

Smokeless Tobacco:

Usage leads to increased tissue inflammation, which contributes to accelerated breakdown of periodontium and causes gingival recession at the site of use.

Cigar and Pipe Smoking:

These forms of smoking pose significant risk factors for attachment loss and severe recession, particularly where plugs are placed for smokeless tobacco, indicating the need for targeted prevention strategies.

Cannabis:

Used for both medical and recreational purposes, cannabis does not contain nicotine but has psychoactive effects (THC). Emerging studies suggest that cannabis may independently contribute to periodontal disease risk, with links to an increased occurrence of periodontal issues being explored.

Smoking significantly increases the risk of complications after dental implant procedures:

Smokers show twice the rate of implant failures compared to non-smokers, highlighting the need for thorough patient evaluations regarding smoking history before implant surgery.

Dental hygienists have a professional obligation to provide tobacco cessation services to help patients quit smoking.

Treatment outcomes in former smokers tend to be comparable to non-smokers and are healthier than those of current smokers:

Benefits of cessation include a reduction in pathogenic bacteria, improved gingival circulation, and an enhanced immune response, reflecting the positive effects of quitting smoking on oral health.